iifl-logo

Dr Reddys Laboratories Ltd Shareholding Pattern

1,200.5
(1.22%)
Apr 24, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Dr Reddys Laboratories Ltd SHAREHOLDING

Mar-2025Dec-2024Sep-2024Jun-2024Mar-2024

Promoter

-

-

-

-

-

Foreign

0%

0%

0%

0%

0%

Indian

26.64%

26.64%

26.64%

26.65%

26.65%

Total Promoter

-

-

-

-

-

Institutions

62.91%

62.98%

63.22%

62.99%

62.79%

Non-Institutions

10.15%

10.22%

9.97%

10.18%

10.37%

Total Non-Promoter

73.06%

73.2%

73.19%

73.17%

73.17%

Custodian

0.29%

0.15%

0.16%

0.17%

0.17%

Total

100%

100%

100%

100%

100%

  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 0.00%

Foreign: 0.00%

Indian: 26.64%

Non-Promoter- 62.91%

Institutions: 62.91%

Non-Institutions: 10.15%

Custodian: 0.29%

Dr Reddys Labs: Related NEWS

Dr. Reddy’s Laboratories Sells 14 ANDAs to Senores Pharma
5 Mar 2025|11:05 AM

Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.

Read More
Top Stocks for - 27th February 2025
26 Feb 2025|09:22 PM

Here are some of the stocks that may see significant price movement today: KPI Green, Tata Power, UltraTech Cement, etc.

Read More
Dr Reddy’s Hyderabad API Unit Gets USFDA VAI Classification
25 Feb 2025|08:42 PM

Dr Reddy's Laboratories third quarter net profit rose 2.5% year-on-year (YoY) to ₹1,413.3 crore. 

Read More
Dr Reddy’s Laboratories Q3 net profit zooms ~3%
24 Jan 2025|10:23 AM

The company logged a growth of 15.9% in its revenue from operations at ₹8,358.60 Crore versus ₹7,215 Crore in Q3FY24.

Read More
Top Stocks for Today - 24th January 2025
24 Jan 2025|07:50 AM

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

Read More
Top Stocks for today - 6th December 2024
6 Dec 2024|09:14 AM

Here are some of the stocks that may see significant price movement today: Dr Reddy’s Laboratories, RITES, Canara Bank, etc.

Read More
Dr Reddy’s launches first immuno-onco drug in India
28 Nov 2024|03:43 PM

Dr Reddy's already signed a license and commercialisation deal for Toripalimab with Shanghai Junshi Biosciences Co. Ltd in 2023.

Read More
Dr Reddy’s Bollaram Facility Receives USFDA Form 483 with 7 Observations
21 Nov 2024|11:14 PM

Dr Reddy’s Laboratories shares has gained a total of 5.62% in the last one year, and 2.45% since the beginning of the year.

Read More
Top Stocks for today - 21st November 2024
21 Nov 2024|07:53 AM

Here are some of the stocks that may see significant price movement today: UPL, Tata Power, JSW Steel, Dr Reddy’s, etc.

Read More
Dr Reddy’s posts 15% y-o-y decline in Q2 net profit at ₹1,255 Crore
6 Nov 2024|09:25 AM

EBITDA for the quarter increased 5% year-on-year to ₹2,280 Crore between July and September 2024, while margins improved modestly to 28.4%.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.